Results 111 to 120 of about 1,439 (152)

Off-label use of oritavancin: a case series on clinical effectiveness, bed-day savings and cost benefits. [PDF]

JAC Antimicrob Resist
Patel A, Walden A, Iyer S, Okoibhole A.
europepmc   +1 more source

Are Oritavancin and Dalbavancin More Cost Effective for Outpatient Parenteral Antimicrobial Therapy at a Veterans Affairs Medical Center? [PDF]

Fed Pract
Hanks D, Jodlowski TZ, Madaras-Kelly K, Diaz J, Vietri N.   +4 more
europepmc   +1 more source

Experience of use of dalbavancin for the treatment of unlicensed indications in a UK tertiary infectious diseases setting. [PDF]

Infection
Darlow CA, Parsons J, Lucy D, Li A, Ratcliffe L, Todd S, Wong N.   +6 more
europepmc   +1 more source

Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview

Global & Regional Health Technology Assessment
Rosario Cultrera
doaj   +1 more source

Model-based quantification of immune response and anti-staphylococcal activity of afabicin in immunocompetent mouse thigh infections to enable predictions of clinical efficacy. [PDF]

Antimicrob Agents Chemother
Saporta R, Nielsen EI, Menetrey A, Cameron DR, Nicolas-Métral V, Friberg LE.   +5 more
europepmc   +1 more source

Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]

Front Microbiol
Frontiers Production Office.
europepmc   +1 more source

A Randomized, Observer-Blinded, Active-Controlled, Phase IIIb Study to Compare IV/Oral Delafloxacin Fixed-Dose Monotherapy With Best Available Treatments in a Microbiologically Enriched Population With Surgical Site Infections: The DRESS Study. [PDF]

Open Forum Infect Dis
Belev N, Tein A, Mangialardi G, Nuti A, Marino Merlo G, Scartoni S, Bertolotti M, Lerro M, Margaritora S.   +8 more
europepmc   +1 more source

The future approach for the management of acute bacterial skin and skin structure infections. [PDF]

Curr Opin Infect Dis
Tiseo G, Falcone M.
europepmc   +1 more source

Is Shorter Better in Oncology Patients, Too? A Retrospective Cohort Study of Short- Versus Long-Course Antibiotic Therapy for Uncomplicated Infections in Solid Tumor Patients Receiving Care in Ambulatory Oncology Clinics. [PDF]

Open Forum Infect Dis
Arena CJ, El-Tatari B, Lovric K, Greenlee SB, Kenney RM, Gadgeel SM, Patterson K, Shallal AB, Alangaden GJ, Davis SL, Veve MP.   +10 more
europepmc   +1 more source

Novel Therapeutic Approaches and Alternatives to Antibiotic Therapy for Drug-Resistant Intra-Abdominal Infections. [PDF]

Antibiotics (Basel)
Toma EA, Enciu O, Matache IM, Porosnicu AL, Calu V, Miron A, Delawan M, Bydon M, Popa MI.   +8 more
europepmc   +1 more source